Managing Expected Returns: Matthew Caruso | Investing With IBD

TL;DR

Investing with IBD discusses market action, lessons on relative strength and follow-through days, and provides stock picks in the oil and gas, biotech, and tech sectors.

Transcript

hello everybody and welcome to investing with ibd sponsored by vantagepoint it's wednesday june 1st 2022 and we're doing a little bit of an earlier taping today arusha pearis is going to be joining me today as always he is a portfolio manager at o'neill global advisors and we got to share some time on ibd live and now here live uh during the market... Read More

Key Insights

• 🥳 Relative strength and follow-through days are important indicators for identifying leading stocks and understanding market momentum.
• ✳️ Diversification within sectors can help manage concentration risks and capture opportunities in different segments.
• 🫵 Understanding the fundamentals and growth potential of a company complements technical analysis and provides a comprehensive view of investment prospects.
• 💪 Innovative products, strong partnerships, and favorable industry dynamics contribute to the potential success of biotech companies.

Questions & Answers

Q: How can follow-through days be used as a guide for investors?

Follow-through days indicate when institutions are returning to the market and serve as a signal for a potential rally. Investors should focus on the expected return rather than the win rate, as successful follow-through days can lead to significant gains in strongly performing individual stocks.

Q: How does Matt Caruso balance concentration risks in sectors like oil and gas?

Caruso diversifies within the sector by selecting stocks from different segments, such as drillers, services, or natural gas companies. He also suggests diversifying exposure over time, adding to positions gradually as the market confirms its strength.

Q: How does fundamental analysis complement technical analysis in stock selection?

Fundamental analysis helps identify growth potential and market dynamics within specific sectors. Technical analysis provides insights into stock timing, entry, and exit points based on chart patterns, relative strength, and overall market behavior.

Q: What factors does Matt Caruso consider when evaluating biotech companies?

Caruso focuses on companies with innovative products, strong growth potential, and promising applications rather than those heavily reliant on drug testing outcomes. Understanding industry drivers and potential catalysts, such as tax incentives, helps inform investment decisions.

Summary & Key Takeaways

• The recent market action has seen the Nasdaq struggling to hold above the 12,000 level, while the NYSE has shown greater strength due to weighting in cyclicals and oil and gas sectors.

• Matt Caruso emphasizes the importance of understanding relative strength and using it to identify leading stocks within sectors. He advises on managing risk and taking profits, with a focus on favorable risk-to-reward ratios.

• The oil and gas sector, particularly oil and gas services companies like P10, presents an opportunity for investment due to supply constraints and potential tax incentives for production increases.

• Halozyme Therapeutics, a biotech company with innovative drug delivery technology, shows strong relative strength and has a promising growth story.

• Box Inc., a tech company specializing in cloud storage and integration, has held up relatively well compared to the broader tech sector. The fundamentals and forward estimates are positive.